These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M. J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934 [Abstract] [Full Text] [Related]
45. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)]. Babini L, Sciascia R, Baccarani M, Emiliani E, Fiacchini M, Franchini A, Lauria F, Tura S. Radiol Med; 1978 Feb 01; 64(2):113-8. PubMed ID: 684251 [No Abstract] [Full Text] [Related]
46. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease. Cunningham J, Mauch P, Rosenthal DS, Canellos GP. Cancer Treat Rep; 1982 Apr 01; 66(4):1015-22. PubMed ID: 7074629 [Abstract] [Full Text] [Related]
47. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. Diehl LF, Perry DJ, Terebelo H, Baldwin PE, Hurwitz M, Kimball DB, Dorn RV. Cancer Treat Rep; 1983 Sep 01; 67(9):827-9. PubMed ID: 6883360 [Abstract] [Full Text] [Related]
48. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results. Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D. J Chemother; 1989 Jul 01; 1(4 Suppl):1254-6. PubMed ID: 16312855 [No Abstract] [Full Text] [Related]
49. Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy. Johnston PG, Ruscetti FW, Connaghan DG, Sullivan FJ, Longo DL. Am J Hematol; 1991 Sep 01; 38(1):54-60. PubMed ID: 1897515 [Abstract] [Full Text] [Related]
50. Reactivation of Chagas' myocarditis during therapy of Hodgkin's disease. Metze K, Lorand-Metze I, De Almeida EA, De Moraes SL. Trop Geogr Med; 1991 Sep 01; 43(1-2):228-30. PubMed ID: 1750119 [Abstract] [Full Text] [Related]
51. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy. Melato M, Falconieri G, Giammarini Barsanti A, Mottola A. Haematologica; 1983 Sep 01; 68(5):675-9. PubMed ID: 6416946 [No Abstract] [Full Text] [Related]
52. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Moore MR, Jones SE, Bull JM, William LA, Rosenberg SA. Cancer; 1973 Jul 01; 32(1):52-60. PubMed ID: 4716784 [No Abstract] [Full Text] [Related]
53. Hodgkin's disease of the bone marrow. Rosenberg SA. Cancer Res; 1971 Nov 01; 31(11):1733-6. PubMed ID: 5121677 [No Abstract] [Full Text] [Related]
54. Will doxorubicin-containing regimens replace MOPP and its variants? Canellos GP, Rosenberg W. Leukemia; 1991 Nov 01; 5 Suppl 1():50-2. PubMed ID: 1890866 [No Abstract] [Full Text] [Related]
55. [Recent progress in the treatment of Hodgkin's disease]. Jacquillat C. Acquis Med Recent; 1977 Nov 01; ():89-98. PubMed ID: 910606 [No Abstract] [Full Text] [Related]
56. Prednisone in MOPP chemotherapy for Hodgkin's disease. Jacobs C, Portlock CS, Rosenberg SA. Br Med J; 1976 Dec 18; 2(6050):1469-71. PubMed ID: 1000259 [Abstract] [Full Text] [Related]
57. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. Frei E, Luce JK, Gamble JF, Coltman CA, Constanzi JJ, Talley RW, Monto RW, Wilson HE, Hewlett JS, Delaney FC, Gehan EA. Ann Intern Med; 1973 Sep 18; 79(3):376-82. PubMed ID: 4748254 [No Abstract] [Full Text] [Related]
58. Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease. Schuler D, Kardos G, Révész T. Neoplasma; 1988 Sep 18; 35(5):599-603. PubMed ID: 3216934 [Abstract] [Full Text] [Related]
59. People with Hodgkin disease: the nursing challenge. Le Blanc DH. Nurs Clin North Am; 1978 Jun 18; 13(2):281-300. PubMed ID: 248744 [No Abstract] [Full Text] [Related]
60. [Chemotherapy of malignant lymphoma]. Horikoshi N, Ogawa M. Gan To Kagaku Ryoho; 1982 Nov 18; 9(11):1903-10. PubMed ID: 6985187 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]